Globus Medical, Inc.GMEDNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank29
3Y CAGR-2.3%
5Y CAGR+4.2%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-2.3%/yr
vs -0.7%/yr prior
5Y CAGR
+4.2%/yr
Recent deceleration
Acceleration
-1.5pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 27.80% | +47.9% |
| 2024 | 18.80% | -14.9% |
| 2023 | 22.10% | -25.8% |
| 2022 | 29.77% | +7.7% |
| 2021 | 27.63% | +22.2% |
| 2020 | 22.60% | -22.6% |
| 2019 | 29.22% | -4.7% |
| 2018 | 30.65% | -5.1% |
| 2017 | 32.29% | -5.6% |
| 2016 | 34.22% | - |